Health Economics Tools and Precision Medicine: Opportunities and Challenges

Veenstra David L. (), Mandelblatt Jeanne, Neumann Peter, Basu Anirban, Peterson Josh F. and Ramsey Scott D.
Additional contact information
Veenstra David L.: University of Washington, Seattle, WA, USA
Mandelblatt Jeanne: Georgetown University, Washington, DC, USA
Neumann Peter: Tufts University, Boston, MA, USA
Basu Anirban: University of Washington, Seattle, WA, USA
Peterson Josh F.: Vanderbilt University Medical Center, Nashville, TN, USA
Ramsey Scott D.: Hutchinson Cancer Research Center, Seattle, WA, USA

Forum for Health Economics & Policy, 2020, vol. 23, issue 1, 14

Abstract: Precision medicine – individualizing care for patients and addressing variations in treatment response – is likely to be important in improving the nation’s health in a cost-effective manner. Despite this promise, widespread use of precision medicine, specifically genomic markers, in clinical care has been limited in practice to date. Lack of evidence, clear evidence thresholds, and reimbursement have been cited as major barriers. Health economics frameworks and tools can elucidate the effects of legal, regulatory, and reimbursement policies on the use of precision medicine while guiding research investments to enhance the appropriate use of precision medicine. Despite the capacity of economics to enhance the clinical and human impact of precision medicine, application of health economics to precision medicine has been limited – in part because precision medicine is a relatively new field – but also because precision medicine is complex, both in terms of its applications and implications throughout medicine and the healthcare system. The goals of this review are several-fold: (1) provide an overview of precision medicine and key policy challenges for the field; (2) explain the potential utility of economics methods in addressing these challenges; (3) describe recent research activities; and (4) summarize opportunities for cross-disciplinary research.

Keywords: genomics; health economics; precision medicine (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://doi.org/10.1515/fhep-2019-0013 (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1

Ordering information: This journal article can be ordered from
https://www.degruyter.com/journal/key/fhep/html

DOI: 10.1515/fhep-2019-0013

Access Statistics for this article

Forum for Health Economics & Policy is currently edited by Dana Goldman

More articles in Forum for Health Economics & Policy from De Gruyter
Bibliographic data for series maintained by Peter Golla ().